Doris M. Ponce, MD, MS

Doris M. Ponce, MD, MS, is director of the Graft-versus-Host Disease (GVHD) Program and cochair of the Center for Hematologic Malignancies Research Council at Memorial Sloan Kettering Cancer Center (MSK).

Dr Ponce is a hematologist-oncologist with specialized postgraduate training in bone marrow transplantation (BMT) and a master of science in clinical trial design. Her academic career is dedicated to patient-oriented research, with a focus on GVHD, which is a major complication of BMT. At MSK, she leads the entire GVHD research portfolio and oversees a multidisciplinary GVHD clinic. She is an active member of the MSK Medicine Steering Committee and served as a member of the Institutional Review Board for 8 years.

Nationally, Dr Ponce contributes to the Blood & Marrow Transplant Clinical Trials Network (BMT CTN) as a protocol team member for the 2303 study and has served on the BMT CTN Toxicity and Supportive Care Committee since January 2024. She is also committed to international education and outreach, regularly participating in lectures and educational initiatives across Latin America.

Dr Ponce recently chaired the first Latin American GVHD Symposium at MSK. Additionally, she is a standing reviewer for the Transplantation, Tolerance, and Tumor Immunology Study Section at the National Institutes of Health, and she reviews for other foundations and institutional research programs.